US FDA greenlights first ever treatment for rare metabolic disorder

Published: 2025-03-26 17:05:25 ET SLNO

March 26 (Reuters) - The U.S. Food and Drug Administration approved Soleno Therapeutics' drug to treat a rare genetic disorder on Wednesday, making it the first treatment available for patients who experience feelings of intense and persistent hunger.

(Reporting by Sneha S K and Bageshri Banerjee in Bengaluru; Editing by Krishna Chandra Eluri and Alan Barona)